Literature DB >> 7971011

Serologic, virologic, and histologic characteristics of chronic phase hepatitis C virus disease in children infected by transfusion.

S Matsuoka1, K Tatara, Y Hayabuchi, Y Taguchi, K Mori, H Honda, S Itou, Y Yuasa, Y Kuroda.   

Abstract

OBJECTIVE: We studied the time course of hepatic dysfunction, seropositivity to hepatitis C virus (HCV) antibodies, viremia, and histologic evidence of hepatic injury to evaluate the course of HCV infection in children infected by blood transfusion. PATIENTS AND METHODS: Twenty-nine patients (ages 4 to 18 years) who underwent open-heart surgeries for congenital heart disease were grouped into three categories based on alterations in serum alanine aminotransferase (ALT) levels: Group A, acute infection; Group B, subacute infection; and Group C, chronic infection.
RESULTS: In Group C, all 13 patients had detectable HCV RNA in serum. In contrast, all patients in Group A had no detectable HCV RNA: In Group B, one of nine patients had detectable HCV RNA and two of four patients examined had persistent chronic hepatitis by histologic criteria. Antibodies directed against C100-3 antigen or core-antigen were more useful than second-generation HCV antibody assays in determining the relationship between viremia and immunologic response. Infection with HCV genotype II and the presence of higher HCV RNA copy numbers were associated with histologic evidence of hepatic damage.
CONCLUSION: An abnormal ALT value is frequently associated with viremia, and biochemically resolved acute infection reflects clearance of HCV. However, a normal ALT does not always reflect an absence of hepatocyte damage and HCV replication in patients with subacute disease. The measures outlined in this study are useful indicators of disease activity during the chronic

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7971011

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  4 in total

1.  Active surveillance of hepatitis C infection in the UK and Ireland.

Authors:  D M Gibb; P E Neave; P A Tookey; M Ramsay; H Harris; K Balogun; D Goldberg; G Mieli-Vergani; D Kelly
Journal:  Arch Dis Child       Date:  2000-04       Impact factor: 3.791

2.  Clinical spectrum and histopathologic features of chronic hepatitis C infection in children.

Authors:  Parvathi Mohan; Camilla Colvin; Chevelle Glymph; Roma R Chandra; David E Kleiner; Kantilal M Patel; Naomi L C Luban; Harvey J Alter
Journal:  J Pediatr       Date:  2007-02       Impact factor: 4.406

3.  Symptomatic and pathophysiologic predictors of hepatitis C virus progression in pediatric patients.

Authors:  Wendy A Henderson; Ravi Shankar; Jordan J Feld; Colleen M Hadigan
Journal:  Pediatr Infect Dis J       Date:  2009-08       Impact factor: 2.129

Review 4.  Hepatitis C virus infection in children and adolescents.

Authors:  James E Squires; William F Balistreri
Journal:  Hepatol Commun       Date:  2017-03-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.